Get all your news in one place.
100's of premium titles.
One app.
Start reading
Euronews
Euronews
Marta Iraola Iribarren

Danish pharma giant Novo to use Anthropic’s Claude to advance AI drug discovery

Novo, previously Novo Nordisk, the Danish pharmaceutical company behind Ozempic, has partnered with Anthropic to accelerate the development of new medicines using artificial intelligence.

“Joining forces with Anthropic will supercharge our R&D organisation and help us on our mission to bring new, transformative health solutions to people living with chronic diseases,“ said Mike Doustdar, president and CEO of Novo, in a press release Wednesday.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.